27 Jun, EOD - Indian

Nifty Pharma 21928.6 (0.55)

Nifty Smallcap 100 18976.8 (0.91)

Nifty IT 38822.95 (-0.44)

Nifty Next 50 68712.4 (0.61)

SENSEX 84058.9 (0.36)

Nifty Bank 57443.9 (0.41)

Nifty 50 25637.8 (0.35)

Nifty Midcap 100 59385.15 (0.27)

27 Jun, EOD - Global

NIKKEI 225 40150.79 (1.43)

HANG SENG 24284.15 (-0.17)

S&P 6232.75 (0.41)

LOGIN HERE

companylogoFabtech Technologies Cleanrooms Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 544332 | NSE Symbol : | ISIN : INE0HSD01011 | Industry : Miscellaneous |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
21-May-2025 26-May-2025 Accounts Audited Results- This is to inform you that a meeting of the Board of Directors is scheduled to be held on Monday, May 26, 2025 to inter-alia consider and approve the Audited (Standalone & Consolidated) Financial Results of the Company for Financial Year ended March 31, 2025. Approval of the Audited Financial Results (Standalone and Consolidated) for the second half year and financial year ended March 31, 2025 along with the Audit Report of the Statutory Auditors with unmodified opinion on (Standalone or Consolidated). (As Per BSE Announcement dated on 26.05.2025)
29-Apr-2025 05-May-2025 Employee Stock Option Fabtech Technologies Cleanrooms Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 inter alia to consider and approve 1. To consider the declaration of 1st Interim Dividend for the F.Y. 2024-25. 2. To consider and approve Fabtech Technologies Cleanrooms Limited - Employee Stock Option Scheme 2025 (FTCL-ESOS 2025) and to extend the same to employees of the existing Subsidiary Company(ies) or Associate Company(ies) of the Company in India or outside India. Outcome for the Board Meeting held on Monday, May 05, 2025 and the brief details of the business transacted at the Board Meeting are: 1. Approval of 'Fabtech Technologies Cleanrooms Limited - Employee Stock Option Scheme 2025' ('FTCL - ESOS 2025'/ 'Scheme'). 2. Declaration of 1st Interim Dividend for the F.Y. 2024-25. 3. Approval for incorporation of the Associate Company in the name and style 'Fabtech Fortline Private Limited' or any other appropriate name, as may be approved by the Ministry of Corporate Affairs, Mumbai. Intimation for Incorporation of the Associate Company in the name and style of 'FABTECH FORTLINE PRIVATE LIMITED' or any other appropriate name, as may be approved by the Minister of Corporate Affairs, Mumbai. (As Per BSE Announcement dated on 05.05.2025)
12-Mar-2025 12-Mar-2025 Change in Other Executives 1. Appointment of CEO and KMP of the Company. 2. Approval for rescheduling/ carry forwarding the utilization of the IPO proceeds allocated to be utilized in the current financial year 2024-25 to the next financial year 2025-26. 3. Reviewed the outcome of IPO.

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +